Merck Expands Protein A Capabilities with JSR Chromatography Acquisition
The company says the acquisition will strengthen downstream antibody manufacturing and help biopharma customers scale more efficiently.
False
The company says the acquisition will strengthen downstream antibody manufacturing and help biopharma customers scale more efficiently.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 7, 2026
2 min read
Mayo Clinic and Thermo Fisher launch a large-scale multi-omics resource designed to reveal disease before symptoms appear
October 5, 2026
4 min read
Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines
September 30, 2026
2 min read
Fayuvi is authorized for pediatric patients with preserved neurodevelopmental function following a study comparing treated children with a natural history cohort
September 28, 2026
2 min read
Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner
False
Affiliations:
Specialties:
Areas of Expertise: